Ticker Details
Bristol-Myers Squibb Co. Bristol-Myers Squibb Co is engaged in discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceuticals products. The company operates in one segment that is Biopharmaceuticals.
IPO Date:	December 31, 1981
Sector:	Healthcare
Industry:	Pharma
Market Cap:	$116.66B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.48 | 1.09%
Avg Daily Range (30 D):	$0.80 | 1.40%
Avg Daily Range (90 D):	$0.76 | 1.30%

Institutional Daily Volume
Avg Daily Volume:	9.37M
Avg Daily Volume (30 D):	8.27M
Avg Daily Volume (90 D):	8.67M

Trade Size
Avg Trade Size (Sh.):	174
Avg Trade Size (Sh.) (30 D):	79
Avg Trade Size (Sh.) (90 D):	82

Institutional Trades
Total Institutional Trades:	130,165
Avg Institutional Trade:	$5.16M
Avg Institutional Trade (30 D):	$8.67M
Avg Institutional Trade (90 D):	$9.69M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	22

Market Closing Trades
Avg Closing Trade:	$58.23M
Avg Closing Trade (30 D):	$133.24M
Avg Closing Trade (90 D):	$135.87M
Avg Closing Volume:	1.09M

News

Jun 13, 2026 @ 10:15 PM How Safe is Bristol Myers Squibb's Dividend? Here'... Source: Reuben Gregg Brewer

Jun 11, 2026 @ 6:02 PM Bristol Myers Squibb Dividend Raise Streak is 18 Y... Source: Thomas Niel

Jun 11, 2026 @ 5:12 PM Takeda AI-Drug Shows Superior Skin Clearance Again... Source: Vandana Singh

Jun 10, 2026 @ 6:35 AM Nxera Joins OpenFold AI Research Consortium Alongs... Source: Nxera Pharma Co., Ltd.

Jun 4, 2026 @ 6:30 AM Better High-Yield Dividend Stock to Buy: Bristol M... Source: Thomas Niel

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$3.47	$.54	$3.47
Diluted EPS	$3.46	$.53	$3.46
Revenue	$48.19B	$12.5B	$48.19B
Gross Profit	$34.26B	$8.41B	$34.26B
Net Income / Loss	$7.06B	$1.09B	$7.06B
Operating Income / Loss	$9.33B	$1.47B	$9.33B
Cost of Revenue	$13.94B	$4.1B	$13.94B
Net Cash Flow	$-129M	$-5508M	$-129M
PE Ratio